Orexigen Therapeutics, Inc. (OREX) Posts Q4 Loss of 9c/Share
Tweet Send to a FriendGet Alerts OREX Hot Sheet
Price: $6.09 +1.16%
Revenue Growth %: 0.0%
Financial Fact:
Net loss: -19.37M
Today's EPS Names:
MGT, RXN, KID, More
Revenue Growth %: 0.0%
Financial Fact:
Net loss: -19.37M
Today's EPS Names:
MGT, RXN, KID, More
Trade OREX Now!
Orexigen Therapeutics, Inc. (NASDAQ: OREX) reported Q4 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $857 thousand versus the consensus estimate of $940 thousand.
For earnings history and earnings-related data on Orexigen Therapeutics, Inc. (OREX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Orexigen Therapeutics, Inc. (OREX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
- Dick's Sporting Goods, Inc. (DKS) Reports In-Line Q1 EPS; Guides Q2 EPS, Comps
- Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
